Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience.

Cinzia MazziniGiulio Vicini Laura Di Leo Daniela MassiStanislao RizzoFabrizio Giansanti

Published in: Life (Basel, Switzerland) (2023)

Endoresection and adjuvant Ru-106 brachytherapy is a valuable conservative option for selected UM patients and can be used both as a primary treatment and as a salvage therapy. It can control melanoma and avoid enucleation, reduce radiation-related complications, and provide tumor tissue for chromosomal analysis and prognostic testing.

Keyphrases

high dose
radiation therapy
early stage
ejection fraction
end stage renal disease
newly diagnosed
prognostic factors
locally advanced
skin cancer
bone marrow
stem cells
low dose
mesenchymal stem cells
rectal cancer
combination therapy
cell therapy
radiation induced
quantum dots
replacement therapy